Sulfadoxine-pyrimethamine for the treatment of Plasmodium falciparum malaria in Gabonese children

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 94, Issue 2, 2000, Pages 188-190

  Deloron, P ^a   Mayombo, J ^a   Le Cardinal, A ^a   Mezui Me Ndong, J ^a   Bruzi Baert, C ^a   Lekoulou, F ^a   Elissa, N ^a  

^a International Centre for Medical Research   (Gabon)

Author keywords

Chemotherapy; Children; Gabon; Malaria; Plasmodium falciparum; Sulfadoxin pyrimethamine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FANSIDAR;

ARTICLE; CHILD; CLINICAL TRIAL; DRUG EFFICACY; GABON; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; TREATMENT FAILURE;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034025625     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(00)90272-4     Document Type: Article

References (24)

1. Anabwani, G. M., Esamai, F. O. & Menya, D. A. (1996). A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children. East African Medical Journal, 73, 155-158.
2. Barat, L. M., Himonga, B., Nkunika, S., Ettling, M., Ruebush, T. K., Kapelwa, W. & Bloland, P. B. (1998). A systematic approach to the development of a rational malaria treatment policy in Zambia. Tropical Medicine and International Health, 3, 535-542.
3. Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B., Steketee, R. & Campbell, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932-937.
4. Bloland, P. B., Kazembe, P. N., Oloo, A. J., Himonga, B., Barat, L. M. & Ruebush, T. K. (1998). Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Tropical Medicine and International Health, 3, 543-552.
5. Bojang, K. A., Schneider, G., Forck, S., Obaro, S. K., Jaffar, S., Pinder, M., Rowley, J. & Greenwood, B. M. (1998). A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 73-76.
6. Deloron, P., Ringwald, P., Luty, A., Renaut, A., Minh, T. N., Mbessy, J. R. & Millet, P. (1999). Relationships between malaria prevalence and malaria-related morbidity in school-children from two villages from Central Africa. American Journal of Tropical Medicine and Hygiene, 61, 99-102.
7. Domarle, O., Migot-Nabias, F., M'Voukani, J. L., Nabias, R., Lu, C. Y., Mayombo, J., Tiga, H. & Deloron, P. (2000). Factors influencing resistance to re-infection by Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene, 62, in press.
8. Elissa, N., Karch, S., Bureau, P., Ollomo, B., Lawoko, M., Yangari, P., Ebang, B. & Georges, A. J. (1999). Malaria transmission in a region of savanna-forest mosaic Haut Ogooué - Gabon. Journal of American Mosquito Control Association, 15, 15-23.
9. Falaschi, F. & Ansaloni, L. (1997). Chloroquine versus pyrimethamine/sulphadoxine in the treatment of uncomplicated P. falciparum malaria in northern Kenya. East African Medical Journal, 74, 275-277.
10. Guéret, D., Migot, F., Ringwald, P., Thibault, P. & le Bras, J. (1992). Stabilité de la résistance de P. falciparum à la chloroquine entre 1987 et 1989 à Mounana, Gabon. Bulletin of the World Health Organization, 70, 621-624.
11. Kremsner, P. G., Winkler, S., Brandts, C., Neifer, S., Bienzle, U. & Graninger, W. (1994). Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. Journal of Infectious Diseases, 169, 467-470.
12. Lell, B., Lehman, L. G., Schmidt-Ott, J. R., Sturchler, D., Handschin, J. & Kremsner, P. G. (1998). Malaria chemotherapy trial at a minimal effective dose of mefloquine/ sulfadoxine/pyrimethamine compared with equivalent doses of sulfadoxine/pyrimethamine or mefloquine alone. American Journal of Tropical Medicine and Hygiene, 58, 619-624.
13. Metzger, W., Mordmuller, B., Graninger, W., Bienzle, U. & Kremsner, P. G. (1995). Sulfadoxine/pyrimethamine or chloroquine/clindamycin treatment of Gabonese school children infected with chloroquine resistant malaria. Journal of Antimicrobial Chemotherapy, 36, 723-728.
14. Muller, O., van Hensbroek, M. B., Jaffar, S., Drakeley, C., Okorie, C., Joof, D., Finder, M. & Greenwood, B. (1996). A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Tropical Medicine and International Health, 1, 124-132.
15. Ndyomugyenyi, R. & Magnussen, P. (1997). In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda. Acta Tropica, 66, 137-143.
16. Philipps, J., Radloff, P. D., Wernsdorfer, W. & Kremsner, P. G. (1998). Follow-up of the susceptibility of Plasmodium falciparum to antimalarials in Gabon. American Journal of Tropical Medicine and Hygiene, 58, 612-618.
17. Richard-Lenoble, D., Kombila, M., Martz, M., Lefèbre, B., Chandenier, J., Gay, F., Billiault, X. & Thérizol-Ferly, M. (1989). Evolution de la résistance de P. falciparum à la chloroquine au Gabon entre 1984 et 1987-88. Annales de la Société belge de Médecine Tropicale, 69, 113-119.
18. Ronn, A. M., Msangeni, H. A., Mhina, J., Wernsdorfer, W. H. & Bygbjerg, I. C. (1996). High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 179-181.
19. Verhoeff, F. H., Brabin, B. J., Masache, P., Kachale, B., Kazembe, P. & Van-der-Kaay, H. J. (1997). Parasitological and haematological responses to treatment of Plasmodium falciparum malaria with sulphadoxine-pyrimethamine in southern Malawi. Annals of Tropical Medicine and Parasitology, 91, 133-140.
20. Wakibara, J. V., Mboera, L. E. & Ndawi, B. T. (1997). Malaria in Mvumi, central Tanzania and the in vivo response of Plasmodium falciparum to chloroquine and sulphadoxine pyrimethamine. East African Medical Journal, 74, 69-71.
21. WHO (1994). Chemotherapy of Malaria and Resistance to Antimalarials. Report of a WHO Scientific Group. Geneva: World Health Organization, Technical Report Series, no 529.
22. WHO (1996). World malaria situation in 1993, part I. Weekly Epidemiological Record, 71, 17-22.
23. Winkler, S., Brandts, C., Wernsdorfer, W. H., Graninger, W., Bienzle, U. & Kremsner, P. G. (1994). Drug sensitivity of Plasmodium falciparum in Gabon. Activity correlations between various antimalarials. Tropical Medicine and Parasitology, 45, 214-218.
24. Wolday, D., Kibreab, T., Bukenya, D. & Hodes, R. (1995). Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene, 89, 654-656.